<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01840202</url>
  </required_header>
  <id_info>
    <org_study_id>S140213</org_study_id>
    <nct_id>NCT01840202</nct_id>
  </id_info>
  <brief_title>Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study</brief_title>
  <official_title>Correlation Between Submacular and Peripapillary Choroidal Tissue and Ocular Blood Flow in Glaucoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glaucoma is a leading cause of blindness worldwide, whose treatment - intraocular pressure&#xD;
      lowering - is only partially effective in preventing disease progression. Accordingly, other&#xD;
      variables, such as ocular blood flow-related factors, have been implicated in disease&#xD;
      pathogenesis. However, most findings involving vascular variables come from partial,&#xD;
      small-scale studies. Furthermore, recent technological advances have identified a number of&#xD;
      ocular blood flow variables that have yet to be tested in large scale trials. Therefore, a&#xD;
      study that specifically aims at uncovering the role of vascular aspects in glaucoma is&#xD;
      needed.&#xD;
&#xD;
      For this purpose, a cross-sectional, observational case-control study will be conducted in&#xD;
      the University Hospitals Leuven. This will be the largest-yet study on the subject, involving&#xD;
      more than 750 patients. This will allow the creation of a specific cohort of patients where&#xD;
      the vascular aspects are thought to be particularly important (low-tension glaucoma). It will&#xD;
      use the largest combination yet of vascular-related measuring techniques (dynamic contour&#xD;
      tonometry, optic coherent tomography, colour Doppler imaging and retinal oximetry)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Demographic and clinical ophthalmology-related examination data will be collected,&#xD;
           including intraocular pressure measurement using dynamic contour tonometry&#xD;
&#xD;
        2. Visual field testing will be performed.&#xD;
&#xD;
        3. Structural damage will be documented by a retinal nerve fiber layer analysis (through&#xD;
           Heidelberg Retinal Tomograph)&#xD;
&#xD;
        4. High Definition Optical coherent tomograph imaging of the submacular and peripapillary&#xD;
           choroidal thickness will be performed.&#xD;
&#xD;
        5. Color Doppler Imaging of the retrobulbar vessels will be performed, with analysis of the&#xD;
           Doppler waveform (peak systolic, end diastolic velocities and resistivity index)&#xD;
&#xD;
        6. Retinal oximetry will be performed with the analysis of the arterial and venous&#xD;
           saturations of retinal vessels&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the Retrobulbar Arteries Doppler Waveform between glaucoma patients and healthy controls</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 hours</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">770</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <condition>Normal Tension Glaucoma</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy volunteers with no family history of glaucoma, an increased or asymmetrical cup/disc ratio or any other optic disc structural change (notching, disc hemorrhage) or an intraocular pressure (IOP) above 21 mmHg that could suggest possible glaucoma suspects.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary open-angle glaucoma</arm_group_label>
    <description>Patients with a characteristic optic disc damage (based on cup/disc ratio, thinning of neuroretinal rim, notching, disk hemorrhages, etc.) and visual field defects, with at least one measurement of IOP of &gt;21 mmHg required</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Tension Glaucoma</arm_group_label>
    <description>Patients with a characteristic optic disc damage (based on cup/disc ratio, thinning of neuroretinal rim, notching, disk hemorrhages, etc.) and visual field defects, with at maximum recorded IOP of &lt; 21 mmHg</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Tertiary referral center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  individuals over 18 years old&#xD;
&#xD;
          -  willing to sign an informed consent and able to comply with the requirements of the&#xD;
             study&#xD;
&#xD;
          -  having no other ocular diseases besides glaucoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of ocular trauma&#xD;
&#xD;
          -  intraocular surgery (except for cataract surgery)&#xD;
&#xD;
          -  eye disease (except glaucoma)&#xD;
&#xD;
          -  systemic diseases with ocular involvement like diabetes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingeborg Stalmans, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000 Leuven</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>April 17, 2013</study_first_submitted>
  <study_first_submitted_qc>April 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2013</study_first_posted>
  <last_update_submitted>May 28, 2015</last_update_submitted>
  <last_update_submitted_qc>May 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Low Tension Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

